FDAnews
www.fdanews.com/articles/175223-gilead-ceo-steps-down-after-20-years

Gilead CEO Steps Down After 20 Years

February 5, 2016

After serving as Gilead Sciences’ CEO for 20 years, John C. Martin has announced that he is stepping down and will assume the role of executive chairman of the company.

Current President and Chief Operating Officer John F. Milligan will assume the CEO post on March 10.

Martin joined Gilead in 1990 and has served as the company’s chief executive since 1996.